Evidence map›Paper›PMID 26116709›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

The α1A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium.

Patrick M Cowley, Guanying Wang, Audrey N Chang, Om Makwana, Philip M Swigart, David H Lovett, James T Stull, Paul C Simpson, Anthony J Baker

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. αInternational journal of molecular sciences · 2023
    Review
  7. Article
  8. α1-Adrenergic receptor regulates papillary muscle and aortic segment contractile function via modulation of store-operated CaJournal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2021
    Article
  9. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.International journal of molecular sciences · 2021
    Review
  10. Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases.American journal of physiology. Heart and circulatory physiology · 2021
    Review
  11. Current Developments on the Role of αFrontiers in cell and developmental biology · 2021
    Review
  12. Emerging therapies for right ventricular dysfunction and failure.Cardiovascular diagnosis and therapy · 2020
    Review
  13. Article
  14. Calcium/calmodulin regulates signaling at the αEuropean journal of pharmacology · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. αAmerican journal of physiology. Heart and circulatory physiology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Patrick M CowleyVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
Guanying WangVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
Audrey N ChangDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Om MakwanaVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
Philip M SwigartVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
David H LovettVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
James T StullDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas.
Paul C SimpsonVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and.
Anthony J BakerVeterans Affairs Medical Center, San Francisco, and Department of Medicine, University California San Francisco, San Francisco, California; and Anthony.Baker@ucsf.edu.
San Francisco VA Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

CATECHOLAMINES AND HYPERTROPHY OF CULTURED HEART CELLSR01HL031113 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SIMPSON, PAUL C · 1985 to 2021
$5.7M
Roles of Myosin Light Chain Kinases in the HeartR01HL080536 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI STULL, JAMES T · 2006 to 2010
$1.9M
Right Heart Function in Health and Chronic Lung DiseaseI01BX000740 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI Anthony J. BAKER · 2011 to 2026
–
Novel therapy for cardiotoxicity of cancer drugsI01BX001970 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI SIMPSON, PAUL C · 2013 to 2016
–
BLRD VA I01 BX000740BLRD VA I01 BX001970NHLBI NIH HHS HL-080536NHLBI NIH HHS HL-31113NHLBI NIH HHS R01 HL031113
6 · The paper itself

Abstract

Dysfunction of the right ventricle (RV) is closely related to prognosis for patients with RV failure. Therefore, strategies to improve failing RV function are significant. In a mouse RV failure model, we previously reported that α1-adrenergic receptor (α1-AR) inotropic responses are increased. The present study determined the roles of both predominant cardiac α1-AR subtypes (α1A and α1B) in upregulated inotropy in failing RV. We used the mouse model of bleomycin-induced pulmonary fibrosis, pulmonary hypertension, and RV failure. We assessed the myocardial contractile response in vitro to stimulation of the α1A-subtype (using α1A-subtype-selective agonist A61603) and α1B-subtype [using α1A-subtype knockout mice and nonsubtype selective α1-AR agonist phenylephrine (PE)]. In wild-type nonfailing RV, a negative inotropic effect of α1-AR stimulation with PE (force decreased ≈50%) was switched to a positive inotropic effect (PIE) with bleomycin-induced RV injury. Upregulated inotropy in failing RV occurred with α1A-subtype stimulation (force increased ≈200%), but not with α1B-subtype stimulation (force decreased ≈50%). Upregulated inotropy mediated by the α1A-subtype involved increased activator Ca(2+) transients and increased phosphorylation of myosin regulatory light chain (a mediator of increased myofilament Ca(2+) sensitivity). In failing RV, the PIE elicited by the α1A-subtype was appreciably less when the α1A-subtype was stimulated in combination with the α1B-subtype, suggesting functional antagonism between α1A- and α1B-subtypes. In conclusion, upregulation of α1-AR inotropy in failing RV myocardium requires the α1A-subtype and is opposed by the α1B-subtype. The α1A subtype might be a therapeutic target to improve the function of the failing RV.

Indexed as

Myocardial ContractionAdrenergic alpha-1 Receptor AgonistsAnimalsCalcium SignalingCells, CulturedHeart FailureMaleMiceMice, Inbred C57BLMyocytes, CardiacMyosinsReceptors, Adrenergic, alpha-1Ventricular Dysfunction, RightAdrenergic alpha-1 Receptor AgonistsMyosinsReceptors, Adrenergic, alpha-1inotropicmyosin regulatory light chainright ventricleα1-adrenergic

Identifiers

PMID26116709
PMCPMC4591405
OpenAlexW1852619401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.